// App-Quantinova.ai

TCT-478 : Effect of different drug-eluting stent design on in-stent restenosis and stent thrombosis

Researchers

Presenter

  • Oskar Angeras

Principal Investigators

  • Per Albertsson

  • Christian Dworeck

  • Inger Haraldsson

  • Dan Ioanes

  • Berglind Libungan

  • Goran Matejka

  • Elmir Omerovic

  • Petur Petursson

  • Truls Ramunddal

  • Wilhelm Ridderstrale

Medical Centers

  • Department of Oncology, Sahlgrenska University Hospital, Goteborg, Sweden

  • Department of Cardiology, Sahlgrenska University Hospital, GOTHENBURG, GOTHENBURG, Sweden

  • Department of Cardiology, Skaraborg Hospital, SKOVDE, GOTHENBURG, Sweden

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Department of Cardiology, NU-hospital group, TROLLHATTAN, GOTHENBURG, Sweden

  • Department of Cardiology, Skaraborg Hospital, SKOVDE, GOTHENBURG, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Restenosis

  • Angina

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved